Branched chain amino acids (BCAAs) have been shown to affect gene expression, protein
metabolism, apoptosis and regeneration of hepatocytes, and insulin resistance. They have …

Introduction Sarcopenia is a major element of malnutrition in liver cirrhosis (LC) and is
present in 30–70% of this population, being associated with a poor overall prognosis due to …

Branched chain amino acids (BCAAs) are involved in various bioprocess such as protein
metabolism, gene expression, insulin resistance and proliferation of hepatocytes. BCAAs …

Introduction and objectives The potential benefits of branched-chain amino acids (BCAAs) in
cirrhosis extend beyond just the improvement of nutritional status. Their effects include …

Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and presents
together with cirrhosis in most cases. In addition to commonly recognized risk factors for …

Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related
mortality worldwide. Unfortunately, only 20% of HCC patients are amenable to curative …

Simple Summary The use of branched-chain amino acid (BCAA) supplements in patients
with cirrhosis and liver cancer has been investigated by numerous studies, with multiple …

Branched‐chain amino acids (BCAAs) constituting of valine, leucine, and isoleucine act as
both substrates of proteins and as key regulators for various nutrient metabolisms. Patients …

Background Dietary supplementation with branched‐chain amino acids (BCAA) is often
used in cirrhotic patients to improve nutritional status. We wanted to explore the evidence for …

Background: Hepatocellular carcinoma (HCC) significantly contributes to the global burden
of cancer. Liver cancer is the third most frequent cause of cancer-related death with HCC …